Regarding liver function tests, there was a significant increase in SGOT in severe and moderate COVID-19 patients compared with controls (P2 < 0.001, P3 < 0.001), while there was a significant increase in SGPT in moderate COVID-19 patients compared to severe COVID-19 patients (P1 = 0.011). Here, GOT1 is linked to COVID-19.